1.07

1.90% 0.02

After Hours: 1.08 0.01 +0.93%

Cardiol Therapeutics Inc (CRDL)

Overview News Price History Option Chain Why CRDL Down? Discussions Forecast

Cardiol Therapeutics Inc stock is traded at $1.07, with a volume of 492.66K. It is up +1.90% in the last 24 hours and down -3.60% over the past month. Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

Previous Close:

$1.05

Open:

$1.07

24h Volume:

492.66K

Relative Volume:

0.85

Market Cap:

$123.34M

Revenue:

Net Income/Loss:

$-26.33M

P/E Ratio:

-3.789

EPS:

-0.2824

Net Cash Flow:

$-17.65M

1W Performance:

+3.88%

1M Performance:

-3.60%

6M Performance:

+7.00%

1Y Performance:

-30.52%

1-Day Range:

$1.055

$1.105

1-Week Range:

$1.03

$1.105

52-Week Range:

$0.88

$1.71

Cardiol Therapeutics Inc Stock (CRDL) Company Profile

Name

Cardiol Therapeutics Inc

Sector

Healthcare (1100)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

CRDL's Discussions on Twitter

Compare CRDL vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CRDL Cardiol Therapeutics Inc	1.07	122.19M	0	-26.33M	-17.65M	-0.2824
TAK Takeda Pharmaceutical Co Adr	16.89	50.65B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.72	41.09B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	35.29	39.45B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	75.42	30.13B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	547.25	23.00B	3.17B	1.29B	1.01B	27.09

Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-02-25	Initiated	H.C. Wainwright	Buy
Jan-28-25	Initiated	Rodman & Renshaw	Buy
Jun-26-24	Initiated	ROTH MKM	Buy
Apr-22-24	Initiated	H.C. Wainwright	Buy

Cardiol Therapeutics Inc Stock (CRDL) Latest News

Jun 29, 2026

Enterprise value to revenue forward of Cardiol Therapeutics Inc. – BOATS:CRDL - TradingView

Jun 29, 2026

Why Cardiol Therapeutics Inc Class A stock is sliding today - Wealth Awesome

Jun 29, 2026

Jun 27, 2026

CRDL SEC FilingsCardiol Therapeu 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 27, 2026

Price to earnings forward of Cardiol Therapeutics Inc. Class A – TSX:CRDL - TradingView

Jun 27, 2026

Enterprise value to revenue forward of Cardiol Therapeutics Inc. Class A – TSX:CRDL - TradingView

Jun 27, 2026

Jun 26, 2026

Cardiol Therapeutics Shareholders Back Board Slate and Auditor at 2026 AGM - TipRanks

Jun 25, 2026

A2PA9E Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Strong shareholder support at Cardiol Therapeutics (CRDL) 2026 AGM as all directors elected - Stock Titan

Jun 25, 2026

Press Release: Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders - Moomoo

Jun 25, 2026